Stargardt Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • ACDN-01 in ABCA4-related Retinopathy (STELLAR)

    Sorry, not currently recruiting here

    This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal injection of ACDN-01.

    San Francisco, California and other locations

Our lead scientists for Stargardt Disease research studies include .

Last updated: